Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,000 | 195,000 | 445,000 | 510,000 | 372,000 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,000 |
| Receivables | 285,000 | 255,000 | 272,000 | 243,000 | 272,000 |
| Inventories | 152,000 | 153,000 | 155,000 | 149,000 | 163,000 |
| Other current assets | 40,000 | 15,000 | 20,000 | 21,000 | 19,000 |
| TOTAL | $667,000 | $652,000 | $922,000 | $951,000 | $883,000 |
| Non-Current Assets | |||||
| PPE Net | 157,000 | 144,000 | 124,000 | 117,000 | 104,000 |
| Investments And Advances | 27,000 | 28,000 | 28,000 | 27,000 | 27,000 |
| Intangibles | 2,000 | 2,000 | 2,000 | 7,000 | 7,000 |
| Other Non-Current Assets | 344,000 | 376,000 | 342,000 | 349,000 | 355,000 |
| TOTAL | $530,000 | $550,000 | $496,000 | $500,000 | $493,000 |
| Total Assets | $1,197,000 | $1,201,000 | $1,416,000 | $1,452,000 | $1,375,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 29,000 | 18,000 | 18,000 | 18,000 |
| Accounts payable and accrued liabilities | 178,000 | 250,000 | 215,000 | 196,000 | 183,000 |
| Accrued Expenses | 565,000 | 624,000 | 719,000 | 814,000 | 780,000 |
| Other current liabilities | N/A | N/A | N/A | N/A | 3,000 |
| TOTAL | $779,000 | $914,000 | $965,000 | $1,056,000 | $1,005,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 486,000 | 290,000 | 304,000 | 308,000 | 311,000 |
| Other Non-Current Liabilities | 76,000 | 95,000 | 354,000 | 346,000 | 344,000 |
| TOTAL | $562,000 | $385,000 | $658,000 | $654,000 | $655,000 |
| Total Liabilities | $1,341,000 | $1,300,000 | $1,623,000 | $1,709,000 | $1,660,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,922 | 125,065 | 124,854 | 124,770 | 124,770 |
| Common Shares | N/A | 62,000 | 62,000 | 62,000 | 62,000 |
| Retained earnings | -280,000 | -243,000 | -346,000 | -388,000 | -406,000 |
| Other shareholders' equity | -29,000 | -29,000 | -32,000 | -32,000 | -34,000 |
| TOTAL | $-144,000 | $-98,000 | $-207,000 | $-257,000 | $-285,000 |
| Total Liabilities And Equity | $1,197,000 | $1,202,000 | $1,416,000 | $1,452,000 | $1,375,000 |